These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37540408)

  • 1. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
    Segura PP; Quintela NV; García MM; Del Barco Berrón S; Sarrió RG; Gómez JG; Castaño AG; Martín LMN; Rubio OG; Losada EP
    Clin Transl Oncol; 2023 Sep; 25(9):2634-2646. PubMed ID: 37540408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).
    Martínez-Garcia M; Álvarez-Linera J; Carrato C; Ley L; Luque R; Maldonado X; Martínez-Aguillo M; Navarro LM; Vaz-Salgado MA; Gil-Gil M
    Clin Transl Oncol; 2018 Jan; 20(1):22-28. PubMed ID: 29086250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
    Santosh V; Rao S
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
    Appay R; Dehais C; Maurage CA; Alentorn A; Carpentier C; Colin C; Ducray F; Escande F; Idbaih A; Kamoun A; Marie Y; Mokhtari K; Tabouret E; Trabelsi N; Uro-Coste E; Delattre JY; Figarella-Branger D;
    Neuro Oncol; 2019 Dec; 21(12):1519-1528. PubMed ID: 31832685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEOM-GEINO clinical guidelines for grade 2 gliomas (2023).
    Vaz-Salgado MÁ; García BC; Pérez IF; Munárriz BJ; Domarco PS; González AH; Villar MV; Caro RL; Delgado MLV; Sánchez JMS
    Clin Transl Oncol; 2024 Nov; 26(11):2856-2865. PubMed ID: 38662171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
    Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
    Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological tumour volumes of gliomas in early and standard 20-40 min
    Unterrainer M; Winkelmann I; Suchorska B; Giese A; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1242-1249. PubMed ID: 29487977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy delays malignant transformation and prolongs survival in patients with IDH-mutant gliomas.
    Liu Y; Chen H; Li G; Zhang J; Yao K; Wu C; Li S; Qiu X
    Cancer Biol Med; 2022 Nov; 19(10):1477-86. PubMed ID: 36350001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Considerations in the Treatment of Grade 3 Gliomas.
    Jo J; Schiff D
    Curr Treat Options Oncol; 2022 Sep; 23(9):1219-1232. PubMed ID: 35913658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification and Diagnosis of Adult-Type Diffuse Gliomas].
    Ohno M; Sugino H
    No Shinkei Geka; 2023 Sep; 51(5):760-770. PubMed ID: 37743327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
    van den Bent MJ; Smits M; Kros JM; Chang SM
    J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
    Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
    Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
    Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
    Clin Transl Oncol; 2018 Jan; 20(1):3-15. PubMed ID: 29124520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEOM clinical guidelines for anaplastic gliomas (2017).
    Balañá C; Alonso M; Hernandez-Lain A; Hernandez A; Perez-Segura P; Pineda E; Ramos A; Sanchez AR; Teixidor P; Verger E; Benavides M
    Clin Transl Oncol; 2018 Jan; 20(1):16-21. PubMed ID: 29058264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.
    Morshed RA; Han SJ; Hervey-Jumper SL; Pekmezci M; Troncon I; Chang SM; Butowski NA; Berger MS
    J Neurooncol; 2019 Jan; 141(2):383-391. PubMed ID: 30498891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade gliomas with isocitrate dehydrogenase wild-type and 1p/19q codeleted: Atypical molecular phenotype and current challenges in molecular diagnosis.
    Zheng L; Zhang M; Hou J; Gong J; Nie L; Chen X; Zhou Q; Chen N
    Neuropathology; 2020 Dec; 40(6):599-605. PubMed ID: 32761642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II/III gliomas.
    Yang P; Cai J; Yan W; Zhang W; Wang Y; Chen B; Li G; Li S; Wu C; Yao K; Li W; Peng X; You Y; Chen L; Jiang C; Qiu X; Jiang T;
    Neuro Oncol; 2016 Aug; 18(8):1099-108. PubMed ID: 26957363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
    Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirty years of progress in the management of low-grade gliomas.
    van den Bent MJ
    Rev Neurol (Paris); 2023 Jun; 179(5):425-429. PubMed ID: 37029057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.